Outset Medical (OM) Cost of Revenue (2019 - 2026)

Outset Medical (OM) has 8 years of Cost of Revenue data on file, last reported at $15.8 million in Q1 2026.

• Quarterly Cost of Revenue rose 15.5% year-over-year to $15.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.4 million (up 25.58% YoY) and the FY2025 annual result came in at $72.7 million, down 3.2% from the prior year.
• Cost of Revenue declined to $15.8 million in Q1 2026 per OM's latest filing, from $31.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $31.2 million in Q4 2025 and bottomed at $13.7 million in Q1 2025.
• The 5-year median for Cost of Revenue is $21.0 million (2024), against an average of $20.9 million.
• The widest annual swing landed in 2022, when Cost of Revenue soared 61.13%; it then slumped 35.14% in 2025.
• Tracing OM's Cost of Revenue over 5 years: stood at $23.6 million in 2022, then slipped by 3.54% to $22.8 million in 2023, then decreased by 9.93% to $20.5 million in 2024, then surged by 52.15% to $31.2 million in 2025, then slumped by 49.53% to $15.8 million in 2026.
• Per Business Quant, the three latest OM Cost of Revenue figures stand at $15.8 million (Q1 2026), $31.2 million (Q4 2025), and $17.8 million (Q3 2025).

Peer Comparison